COMPASS Pathways (CMPS) Net Equity Issued and Repurchased (2020 - 2026)
COMPASS Pathways (CMPS) posted quarterly Net Equity Issued and Repurchased of $140.6 million for Q1 2026, little changed year-over-year from $140.4 million in Q1 2025, and little changed quarter-over-quarter from $140.4 million in Q1 2025.
COMPASS Pathways (CMPS) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
COMPASS Pathways (CMPS) has reported Net Equity Issued and Repurchased for 6 consecutive years, with $140.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased changed 0.2% year-over-year to $140.6 million; the TTM figure through Mar 2026 stood at $140.6 million (changed 0.2% YoY), while the FY2025 annual figure was $140.4 million, up 435.33% from the prior year.
- Net Equity Issued and Repurchased held at $140.6 million in Q1 2026 per CMPS's latest filing, from $140.4 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $140.6 million in Q1 2026 and bottomed at -$41000.0 in Q4 2023.
- Historically, Net Equity Issued and Repurchased has averaged $56.6 million across 5 years, with a median of $26.6 million in 2023.
- Annual changes were most pronounced in 2023 — Net Equity Issued and Repurchased tumbled 109.32% — and 2024, when it jumped 2106.99%.
- COMPASS Pathways' Net Equity Issued and Repurchased stood at $440000.0 in 2022, then sank by 109.32% to -$41000.0 in 2023, then soared by 64048.78% to $26.2 million in 2024, then jumped by 435.33% to $140.4 million in 2025, then climbed by 0.2% to $140.6 million in 2026.
- Business Quant data shows CMPS's Net Equity Issued and Repurchased at $140.6 million in Q1 2026, $140.4 million in Q1 2025, and $26.2 million in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | - |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | - |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | - |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | - |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | - |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 4.88 Mn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | - |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | - |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | - |
| 10 | COMPASS Pathways | 1.83 Bn | 1.83 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 140.64 Mn |
| Mar 31, 2026 | 140.64 Mn |
| Mar 31, 2025 | 140.36 Mn |
| Mar 31, 2025 | 140.36 Mn |
| Mar 31, 2024 | 26.22 Mn |
| Mar 31, 2024 | 26.22 Mn |
| Dec 31, 2023 | -41,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Sep 30, 2023 | 116.86 Mn |
| Sep 30, 2023 | 116.86 Mn |
| Jun 30, 2023 | 26.93 Mn |
| Jun 30, 2023 | 26.93 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 440,000.00 |
| Dec 31, 2022 | 440,000.00 |
| Dec 31, 2020 | -132.82 Mn |
| Dec 31, 2020 | -132.82 Mn |
| Sep 30, 2020 | 76.85 Mn |
| Sep 30, 2020 | 76.85 Mn |